28.11.2022 • News

TotalEnergies to Build Recycling Unit for PP

France’s TotalEnergies said it plans to build a new production line for high-performance recycled polypropylene used in automotive applications at its polymer production site in Carling, France.

Since 2016, the Saint-Avold petrochemical platform has produced high-end value-added compounds for the automotive industry. The new line earmarked for start-up in 2024 will have capacity for 15,000 t/y of polypropylene compounds containing up to 100% recycled plastic materials.

The output will be part of TotalEnergies’ recently launched new RE:clic low-carbon polymer portfolio, which is based on recycled material and bio-feedstocks. The materials of its related RE:use polymer range obtained through a mechanical recycling process meet the highest quality standards and technical requirements of the automotive industry, the French company said.

© OceanProd/ liscence free
© OceanProd/ liscence free

After doubling the capacity at subsidiary Synova, which it claims is “the French leader in the production of recycled polypropylene,” Total said the new investment further strengthens its leading position in high value-added recycled polymers.

With the ability to recycle both post-consumer waste and end-of-life automotive parts, the company said the new line will help address the challenge of the circular economy in Europe. Total’s goal is to increase the share of circular polymers in its portfolio to 30% by 2030.

Author: Dede Williams, Freelance Journalist

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read